Know Cancer

or
forgot password

    • cancer clinical trials in iowa city, IA

    • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Melanoma (Skin)
    Nutrition Intervention in Treating Women With Breast Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Breast Cancer
    Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Colorectal Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Prostate Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Breast Cancer
    SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Lymphoma
    Combination Chemotherapy in Treating Children With Lymphoma
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Lymphoma
    Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Leukemia
    Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Cardiac Toxicity, Lymphoma
    Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Head and Neck Cancer
    Surgery in Treating Patients With Prostate Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Sarcoma
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Head and Neck Cancer, Oral Complications
    Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Head and Neck Cancer
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Hormone Therapy in Treating Patients With Prostate Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Prostate Cancer, Sexual Dysfunction and Infertility
    Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lymphoma
    Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Leukemia
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Leukemia, Myelodysplastic Syndromes
    Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Sarcoma
    Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Leukemia
    STI571 in Treating Patients With Recurrent Leukemia
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Leukemia
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Brain and Central Nervous System Tumors
    Paclitaxel in Treating Patients With Ovarian Stromal Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Ovarian Cancer
    Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia, Lymphoma
    Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Lymphatic Malformations
    Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lymphoma
    Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Myelodysplastic Syndromes
    Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Prostate Cancer
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Multiple Myeloma, Plasma Cell Neoplasm
    Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Multiple Myeloma and Plasma Cell Neoplasm
    Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia, Lymphoma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Breast Cancer
    Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Brain and Central Nervous System Tumors, Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neuroblastoma, Pheochromocytoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Esophageal Cancer, Gastric Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Breast Cancer
    S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Kidney Cancer
    Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lymphoma, Neuroblastoma, Sarcoma
    Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lung Cancer
    Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Holden Comprehensive Cancer Center at University of Iowa

    Trial Locations
    Holden Comprehensive Cancer Center at University of Iowa
    Veterans Affairs Medical Center - Iowa City
    Metastatic Cancer, Prostate Cancer
    Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Anaplastic Large Cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Brain Tumor, Central Nervous System Tumor
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Kidney Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia
    Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cervical Cancer